May 2019

GLOBAL UPDATE – Cross-Border M&A Guide

Published on: May 9 2019
Contributed by: Adam O. Emmerich, Robin Panovka, Raaj S. Narayan and Matthew T. Carpenter, Wachtell, Lipton, Rosen & Katz (New York)

Cross-Border M&A Guide Wachtell, Lipton, Rosen & Katz recently published the inaugural edition of their Cross-Border M&A Guide, which is available here. This new Cross-Border M&A Guide covers the key U.S. legal considerations not only for acquisitions of U.S. companies by non-U.S. companies (or “inbound” M&A transactions), but also for acquisitions of non-U.S. companies, including … Continued

Editor's Note: This submission was contributed by Adam O. Emmerich, Robin Panovka, Raaj S. Narayan and Matthew T. Carpenter.

More

DUTCH UPDATE – Bill implementing the Shareholders’ Rights Directive: what it means for Dutch listed companies

Published on: May 6 2019
Contributed by: Leo Groothuis (Partner), Geert Raaijmakers (Partner), Paul van der Bijl (Partner) and Maarten Buma (Partner), NautaDutilh (The Netherlands).

Bill implementing the Shareholders’ Rights Directive: what it means for Dutch listed companies On 2 April 2019, the bill implementing the revised Shareholder Rights Directive was adopted by the Lower House of Parliament. The bill was amended to take into account a number of modifications to the initial draft. The implementation of Directive 2017/628/EU to … Continued

Editor’s Note: Leo Groothuis advises clients on public M&A and on a wide variety of other domestic and cross-border transactions, as well as take-over defenses and shareholder activism. Geert Raaijmakers specializes in corporate governance, corporate structuring and joint ventures and on pension fund governance.  Paul van der Bijl specializes in IPOs, follow-on offerings, public M&A, anti-takeover defenses, corporate governance and complex cross-border transactions. Maarten Buma specializes in corporate law.

More

Page 1 of 1

Search Posts

Categories

Monthly Archives

The views expressed herein are solely those of the author and have not been endorsed, confirmed, or approved by XBMA or any of the editors of XBMA Forum, nor by XBMA’s founders, members, contributors, academic partners, advisory board members, or others. No inference to the contrary should be drawn.